Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

45 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The A.L.A.N. score identifies prognostic classes in advanced biliary cancer patients receiving first-line chemotherapy.
Salati M, Caputo F, Cunningham D, Marcheselli L, Spallanzani A, Rimini M, Gelsomino F, Reggiani-Bonetti L, Andrikou K, Rovinelli F, Smyth E, Baratelli C, Kouvelakis K, Kalaitzaki R, Gillbanks A, Michalarea V, Cascinu S, Braconi C. Salati M, et al. Among authors: andrikou k. Eur J Cancer. 2019 Aug;117:84-90. doi: 10.1016/j.ejca.2019.05.030. Epub 2019 Jul 2. Eur J Cancer. 2019. PMID: 31276980 Free article.
[Treatment of pancreatic cancer. Actuality and perspective].
Bittoni A, Andrikou K, Lanese A, Santoni M, Pellei C, Faloppi L, Del Prete M, Giampieri R, Cascinu S. Bittoni A, et al. Among authors: andrikou k. Recenti Prog Med. 2015 May;106(5):208-16. doi: 10.1701/1868.20404. Recenti Prog Med. 2015. PMID: 25994537 Italian.
HER family receptor expression and prognosis in pancreatic cancer.
Bittoni A, Mandolesi A, Andrikou K, Santoni M, Alfonsi S, Lanese A, Loretelli C, Pellei C, Piva F, Scarpelli M, Cascinu S. Bittoni A, et al. Among authors: andrikou k. Int J Biol Markers. 2015 Jul 22;30(3):e327-32. doi: 10.5301/jbm.5000157. Int J Biol Markers. 2015. PMID: 26109364 Free article.
The value of lactate dehydrogenase serum levels as a prognostic and predictive factor for advanced pancreatic cancer patients receiving sorafenib.
Faloppi L, Bianconi M, Giampieri R, Sobrero A, Labianca R, Ferrari D, Barni S, Aitini E, Zaniboni A, Boni C, Caprioni F, Mosconi S, Fanello S, Berardi R, Bittoni A, Andrikou K, Cinquini M, Torri V, Scartozzi M, Cascinu S; Italian Group for the Study of Digestive Tract Cancer (GISCAD). Faloppi L, et al. Among authors: andrikou k. Oncotarget. 2015 Oct 27;6(33):35087-94. doi: 10.18632/oncotarget.5197. Oncotarget. 2015. PMID: 26397228 Free PMC article. Clinical Trial.
Mismatch repair deficiency may affect clinical outcome through immune response activation in metastatic gastric cancer patients receiving first-line chemotherapy.
Giampieri R, Maccaroni E, Mandolesi A, Del Prete M, Andrikou K, Faloppi L, Bittoni A, Bianconi M, Scarpelli M, Bracci R, Scartozzi M, Cascinu S. Giampieri R, et al. Among authors: andrikou k. Gastric Cancer. 2017 Jan;20(1):156-163. doi: 10.1007/s10120-016-0594-4. Epub 2016 Jan 21. Gastric Cancer. 2017. PMID: 26796888
45 results